Effects of Arousal and Stress in Anxiety
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00026559|
Recruitment Status : Completed
First Posted : November 12, 2001
Last Update Posted : August 4, 2022
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
This study has several parts. One part will examine the influence of factors such as personality and past experience on reactions to unpleasant stimuli. Others will examine the effect of personality and emotional and attentional states on learning and memory.
When confronted with fearful or unpleasant events, people can develop fear of specific cues that were associated with these events as well as to the environmental context in which the events occurred via a process called classical conditioning. Classical conditioning has been used to model anxiety disorders, but the relationship between stress and anxiety and conditioned responses remains unclear. This study will examine the relationship between cued conditioning and context conditioning . This study will also explore the acquisition and retention of different types of motor, emotional, and cognitive associative processes during various tasks that range from mildly arousing to stressful.
|Condition or disease||Intervention/treatment||Phase|
|Healthy Volunteers||Device: Shock Device Device: Auditory Startle Device||Not Applicable|
Objective: Fear and anxiety are adaptive responses to different types of threats. Fear is a short-duration response evoked by explicit threat cues and anxiety a more sustained state of apprehension evoked by unpredictable threat. This protocol studied fear using Pavlovian fear conditioning in two studies. Studies 1 and 3. Study 2 focused on anxiety. Studies 1 and 3 will be discontinued to focus uniquely on the study of anxiety. Specifically, we will examine the interactions between anxiety induced experimentally using verbal threat and cognitive processes. We will seek to 1) characterize the effect of anxiety on key cognitive processes including working memory and attention control and 2) examine the extent to which performance of cognitive tasks distract from anxiety.
Study population: This more-than-minimal-risk protocol will test medically and psychiatrically healthy volunteers aged 18-50. Pregnant or nursing women will be excluded.
Method: Fear and anxiety will be measured using the startle reflex to brief and loud sounds. Fear conditioning will be assessed using shock as unconditioned stimulus. Cognitive performance will be examined during periods of unpredictable shock anticipation.
Outcome measures: The study will include cognitive performance and measure of aversive states, primarily the startle reflex.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1530 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Official Title:||Effects of Arousal and Stress on Classical Conditioning|
|Actual Study Start Date :||January 10, 2001|
|Actual Primary Completion Date :||July 28, 2022|
|Actual Study Completion Date :||July 28, 2022|
Experimental: Threat Conditions
threat of shock and auditory startle
Device: Shock Device
Device: Auditory Startle Device
Auditory Startle Device
- Startle Reflex [ Time Frame: study visit ]startle reflex
- Performance on cognitive tasks [ Time Frame: study visit ]performance on cognitive tasks
- Cognitive tests [ Time Frame: during study visit ]performance on standard cognitive tests (e.g. working memory capacity
- psychological questionnaires [ Time Frame: during study visit ]psychological questionnaires (Spielberger state and trait anxiety)
- Skin conductance [ Time Frame: during study visit ]Skin conductance
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||18 Years to 50 Years (Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||Yes|
- INCLUSION CRITERIA:
- Males and females
- Age 18-50
- Any current ongoing medical illness
- Current Axis I disorders
- Past significant psychiatric disorders (e.g., psychotic disorders) according to DSM-IV
- Current alcohol or substance abuse according to DSM-IV criteria
- History of alcohol or substance dependence based on DSM-IV criteria within 6 months prior to screening
- Current psychotropic medication use
- Current or past organic central nervous system disorders, including but not limited to seizure disorder or neurological symptoms of the wrist and arms (e.g., carpal tunnel syndrome). The latter exclusion is for shock studies only.
- Positive urine toxicology screen
- Employees of NIMH or an immediate family member of a NIMH employee.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00026559
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|
|Principal Investigator:||Monique Ernst, M.D.||National Institute of Mental Health (NIMH)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
|Responsible Party:||National Institute of Mental Health (NIMH)|
|Other Study ID Numbers:||
|First Posted:||November 12, 2001 Key Record Dates|
|Last Update Posted:||August 4, 2022|
|Last Verified:||July 28, 2022|
|Individual Participant Data (IPD) Sharing Statement:|
|Plan to Share IPD:||No|
|Plan Description:||.We will provide de-identified data to repositories but no identifiable data.|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||Yes|